Filing Details

Accession Number:
0001610717-23-000416
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-20 17:10:14
Reporting Period:
2023-12-18
Accepted Time:
2023-12-20 17:10:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628171 Revolution Medicines Inc. RVMD Biological Products, (No Disgnostic Substances) (2836) 472029180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800668 Jack Anders C/O Revolution Medicines, Inc.
700 Saginaw Drive
Redwood City CA 94063
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-18 1,775 $25.90 76,416 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
  2. Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
  3. This transaction was executed in multiple trades in prices ranging from $25.9017 to $25.9385, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. Includes 37,326 RSUs.